BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
54.93
-0.24 (-0.44%)
Jun 30, 2025, 10:34 AM - Market open

BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $10.53 billion as of June 30, 2025. Its market cap has decreased by -33.85% in one year.

Market Cap
10.53B
Enterprise Value
9.90B
1-Year Change
-33.85%
Ranking
Category
Stock Price
$54.93

Market Cap Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $10.53B, an increase of 2,275.79%. That is a compound annual growth rate of 12.99%.

History

DateMarket Cap% Change
Jun 27, 202510.58B-15.54%
Dec 31, 202412.53B-31.03%
Dec 29, 202318.16B-5.57%
Dec 30, 202219.23B18.58%
Dec 31, 202116.22B1.90%
Dec 31, 202015.92B4.81%
Dec 31, 201915.19B0.17%
Dec 31, 201815.16B-3.18%
Dec 29, 201715.66B9.92%
Dec 30, 201614.25B-15.66%
Dec 31, 201516.89B26.72%
Dec 31, 201413.33B33.25%
Dec 31, 201310.00B64.58%
Dec 31, 20126.08B54.81%
Dec 30, 20113.93B42.26%
Dec 31, 20102.76B45.68%
Dec 31, 20091.89B6.63%
Dec 31, 20081.78B-48.15%
Dec 31, 20073.43B128.90%
Dec 29, 20061.50B87.98%
Dec 30, 2005796.50M93.28%
Dec 31, 2004412.10M-16.92%
Dec 31, 2003496.00M31.08%
Dec 31, 2002378.40M-36.33%
Dec 31, 2001594.30M67.03%
View and export this data all the way back to 1999. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 696.15B
Johnson & Johnson 366.71B
AbbVie 322.03B
Novo Nordisk 304.96B
UnitedHealth Group 280.41B
Novartis AG 235.85B
Abbott Laboratories 233.80B
AstraZeneca 217.42B
Market Cap Rankings